Option chain shows key data for Exicure's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Exicure.

Exicure (NASDAQ:XCUR) Stock, Option Chain

Exicure

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Palantir, Salesforce, Okta, Meta, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

BOXL

BWNB

COGT

DATS

GDTC

GETY

GORO

HCWC

KUKE

Infrared Cameras Holdings, Inc. - Common Stock

MSAI

NARI

RIME

SBEV

SLRN

SYRA

XCUR

XTIA

Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket

marvell technology shutter

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BSLK

CNEY

CRGY

CTNT

ENSC

ESGL

GSX Techedu Inc. American Depositary Shares

GOTU

HRTX

HTOO

LUNR

MRVL

ORIS

PSTG

SOAR

TANH

VIRX

Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Netflix, TSMC, American Express, Moderna, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

AKTS

ALLT

APTO

ARQQ

CDXC

DBGI

ELAB

KULR

LION

NIVF

Nuveen California Dividend Advantage Municipal Fund 2

QMCO

QUBT

RGTI

UXIN

XTKG

Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Exicure Inc

Curate

Press Releases

Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting

Exicure, Inc. Announces 1-for-5 Reverse Stock Split

Exicure, Inc. Announces Proposed Settlement of Securities Class Action Litigation

Exicure, Inc. Receives Extension from Nasdaq Hearings Panel

Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results

Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes

Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech

Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.

Exicure, Inc. (Nasdaq: XCUR) Announces Issuance of New Patent in Australia

Exicure, Inc. Reports Full Year 2024 Financial Results

Achieve Life Sciences, Inc. - Common Shares

Achieve Life Sciences

Adagene Inc. - ADS, each representing 1.25 ordinary shares

Adagene

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Anixa Biosciences

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Atossa Therapeutics

Aerovate Therapeutics, Inc. - Common Stock

Aerovate Therapeutics

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

Climb Bio

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

Caribou Biosciences

CervoMed

Genelux

HilleVax

Macrogenics

OncoCyte

ProKidney Corp. - Class A Ordinary Shares

ProKidney

TScan Therapeutics

Tenaya Therapeutics

Vor Biopharma

Vaxart

Whitehawk Therapeutics, Inc. - Common Stock

Whitehawk Therapeutics

Exagen

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharma

Zura Bio Limited - Class A Ordinary shares

Zura Bio

Chardan Capital

Comments

Exicure

Exicure (XCUR) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga